After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Alkermes plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Alkermes plc is $5.05B. A total of 1.75 million shares were traded on the day, compared to an average of 1.74M shares.
In the most recent transaction, Hopkinson Craig C. sold 9,221 shares of ALKS for 31.50 per share on Dec 05 ’24. After the transaction, the EVP R&D, Chief Medical Officer now owns 59,730 company shares. In a previous transaction on Dec 05 ’24, Hopkinson Craig C. bought 9,221 shares at 31.50 per share.
Among the insiders who sold shares, Hopkinson Craig C. disposed of 14,349 shares on Dec 04 ’24 at a per-share price of $30.77. This resulted in the EVP R&D, Chief Medical Officer holding 68,951 shares of ALKS after the transaction. In another insider transaction, Hopkinson Craig C. bought 14,349 shares at $30.77 per share on Dec 04 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ALKS has a high of $32.88 and a low of $22.90.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ALKS’s latest balance sheet shows that the firm has $536.31M in Cash & Short Term Investments as of fiscal 2021. There were $416.21M in debt and $471.29M in liabilities at the time. Its Book Value Per Share was $7.99, while its Total Shareholder’s Equity was $1.11B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALKS is Buy with a score of 4.14.
